Abstract
Twenty-seven Escherichia coli test strains that were not susceptible to cephalothin were tested for susceptibility to cefazolin, cefamandole, and ceforanide. By zone-size criteria (≥ 18 mm), 67% of E. coli were susceptible to cefazolin and cefamandole, and 93% were susceptible to ceforanide. By microtiter assay (MIC ≤ 8 μg/ml), 88% were susceptible to cefazolin and cefamandole, and 94% were susceptible to ceforanide. The results support susceptibility testing of E. coli with specific first- or second-generation cephalosporins rather than with class agents.
Original language | English |
---|---|
Pages (from-to) | 151-153 |
Number of pages | 3 |
Journal | Clinical Therapeutics |
Volume | 7 |
Issue number | 2 |
State | Published - 1985 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)